Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May;41(3):541-553.
doi: 10.1007/s10545-018-0156-5. Epub 2018 Apr 13.

Recognizable phenotypes in CDG

Affiliations
Review

Recognizable phenotypes in CDG

Carlos R Ferreira et al. J Inherit Metab Dis. 2018 May.

Abstract

Pattern recognition, using a group of characteristic, or discriminating features, is a powerful tool in metabolic diagnostic. A classic example of this approach is used in biochemical analysis of urine organic acid analysis, where the reporting depends more on the correlation of pertinent positive and negative findings, rather than on the absolute values of specific markers. Similar uses of pattern recognition in the field of biochemical genetics include the interpretation of data obtained by metabolomics, like glycomics, where a recognizable pattern or the presence of a specific glycan sub-fraction can lead to the direct diagnosis of certain types of congenital disorders of glycosylation. Another indispensable tool is the use of clinical pattern recognition-or syndromology-relying on careful phenotyping. While genomics might uncover variants not essential in the final clinical expression of disease, and metabolomics could point to a mixture of primary but also secondary changes in biochemical pathways, phenomics describes the clinically relevant manifestations and the full expression of the disease. In the current review we apply phenomics to the field of congenital disorders of glycosylation, focusing on recognizable differentiating findings in glycosylation disorders, characteristic dysmorphic features and malformations in PMM2-CDG, and overlapping patterns among the currently known glycosylation disorders based on their pathophysiological basis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

Carlos R. Ferreira, Ruqaiah Altassan, Rita Francesco, Dorinda Marquez-Da-Silva, Jaak Jaeken and Eva Morava declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
Facial recognition analysis of patients with PMM2-CDG. A: Composite photo created by averaging the extracted mathematical information of the photos in the control cohort. B: Composite photo obtained from images of patients with PMM2-CDG. C: Score distribution of the binary comparison between unaffected controls and patients with PMM2-CDG. D: ROC curve with pertinent statistics obtained after conducting 10 random splits (true positive rate on the ordinate, true negative rate on abscissa).
Figure 2
Figure 2
Diagram on the different steps in lipid-linked oligosaccharide assembly.

References

    1. Al Teneiji A, Bruun TUJ, Sidky S, et al. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II. Mol Genet Metab. 2017;120:235–242. - PubMed
    1. Al-Maawali AA, Miller E, Schulze A, et al. Subcutaneous fat pads on body MRI–an early sign of congenital disorder of glycosylation PMM2-CDG (CDG1a) Pediatr Radiol. 2014;44:222–225. - PubMed
    1. Antoun H, Villeneuve N, Gelot A, et al. Cerebellar atrophy: an important feature of carbohydrate deficient glycoprotein syndrome type 1. Pediatr Radiol. 1999;29:194–198. - PubMed
    1. Artigas J, Cardo E, Pineda M, et al. Phosphomannomutase deficiency and normal pubertal development. J Inherit Metab Dis. 1998;21:78–79. - PubMed
    1. Barone R, Carrozzi M, Parini R, et al. A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation. J Neurol. 2015;262:154–164. - PubMed

Publication types

MeSH terms